Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC:
Preferred Pharmaceuticals recalls Losartan Potassium Tablets (50mg) with NDC 68788-0048-03 and 68788-0048-09 due to presence of an impurity that may pose health risks. Affected products include 30-count and 90-count bottles.
Recall notice
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
Contact the company & request your remedy
What happened, in plain English
Preferred Pharmaceuticals is recalling Losartan Potassium Tablets (50mg) because they contain an impurity that could be harmful. This recall affects specific bottle sizes and production lots that were sold with a prescription. Read more at govinfonow.com/recall/39127-preferred-pharmaceuticals-recalls-losartan-50mg-tablets-due-to-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39127-preferred-pharmaceuticals-recalls-losartan-50mg-tablets-due-to-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1051-2019
Cite this page
“Preferred Pharmaceuticals Recalls Losartan 50mg Tablets Due to Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39127-preferred-pharmaceuticals-recalls-losartan-50mg-tablets-due-to-impurity-risk. Based on FDA recall #D-1051-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1051-2019%22&limit=1).
Why it’s dangerous
The tablets contain an impurity called N-Methylnitrosobutyric acid (NMBA), which was identified during manufacturing quality checks. This impurity may pose health risks, though the exact nature of the risk is not specified in the recall notice.
Who’s affected
Prescription holders of the recalled Losartan Potassium Tablets (50mg) with specific NDC numbers and expiration dates are affected. Individuals using these medications for blood pressure control are most at risk.
How to tell if you have this one
Check for the product name 'Losartan Potassium Tablets, USP, 50 mg' with NDC numbers 68788-0048-03 (30-count) or 68788-0048-09 (90-count). The affected bottles have specific expiration dates and lot numbers listed in the recall notice.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Identify the NDC number and expiration date on the bottle to confirm if it matches the recalled products.
Questions people ask
Why is this medication being recalled?
The recall is due to the presence of an impurity called N-Methylnitrosobutyric acid (NMBA) that was identified during manufacturing quality checks.
What should I do if I have the recalled medication?
The recall notice does not specify a remedy or action for affected products. Check the product details to confirm if it is recalled and contact the manufacturer for further instructions.
Are there any safety risks associated with this impurity?
The recall notice states that the impurity may pose health risks, but it does not specify the exact risks or how severe they are.
Contact Preferred Pharmaceuticals
We’ve drafted a message you can send Preferred Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1051-2019 — Preferred Pharmaceuticals Preferred Pharmaceuticals Hello, I own a Preferred Pharmaceuticals that is covered by recall D-1051-2019 from Preferred Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1051-2019 (March 6, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1051-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.